Skip to main content

Type 2 Diabetes with Cardiovascular Diseases

Hightower has worked in managing diabetes and cardiovascular health to improve quality of life.

                       

About Type 2 Diabetes with Cardiovascular Diseases (CVD)

Cardiovascular diseases (CVD) and type 2 diabetes are two of the leading causes of health complications worldwide, often impacting individuals simultaneously. CVD encompasses heart disease, stroke, and other conditions affecting the blood vessels. Type 2 diabetes disrupts the body’s ability to regulate blood sugar. At Wellnext, we recognize the interconnectedness of these conditions and are committed to a two-pronged research approach.

We conducted clinical trials that addressed both CVD and type 2 diabetes. Our study tested the effectiveness of an innovative, clinic-level educational intervention to improve the management of patients with type 2 diabetes mellitus and cardiovascular disease.

Current Status

Not Recruiting

Study Count

1

Frequently Asked Questions

Are there any additional lifestyle recommendations or support provided to participants in clinical trials for type 2 diabetes with CVD?

In addition to medication interventions, clinical trials for type 2 diabetes with cardiovascular diseases may include lifestyle interventions such as dietary counseling, exercise programs, smoking cessation support, and weight management strategies.

How long do clinical trials for type 2 diabetes with CVD typically last?

Clinical trials for type 2 diabetes with cardiovascular disease vary in duration depending upon several factors. Some trials may involve relatively short-term interventions with follow-up assessments over several months, while others may have longer follow-up periods extending over several years to evaluate sustained treatment effects and long-term cardiovascular outcomes.

Can participants in clinical trials for CVD type 2 diabetes continue taking their current medications?

The eligibility criteria and treatment protocols for clinical trials for type 2 diabetes with cardiovascular diseases may vary depending on the study design and investigational treatment being evaluated. Patients interested in participating in a clinical trial should discuss their medications with the study team to determine eligibility and potential treatment adjustments.

How do clinical trials for type 2 diabetes with cardiovascular disease (CVD) differ from standard diabetes trials?

Clinical trials for type 2 diabetes with cardiovascular disease focus on evaluating treatments that not only manage blood sugar levels but also reduce the risk of cardiovascular events such as heart attack, stroke, or cardiovascular death.

Close Menu